Richard is a Director within the Monitor Deloitte, Health Economics and Market Access team in Brussels, Belgium. He is a member of the Life Sciences EMEA leadership team, in which he leads several cross-functional NextGen Therapy commercialization topics. He brings a strong background in global product launches, including within cell and gene therapy, value and access, health economics and Go-to-market strategy design and deployment.